Arenavirus diagnostics market seen reaching $1.91 billion by 2030

By AI, Created 5:16 PM UTC, May 18, 2026, /AGP/ – The Business Research Company says the arenavirus diagnostics market will grow to $1.91 billion by 2030, up from $1.31 billion in 2025, as demand rises for faster detection of viral hemorrhagic fevers. North America led the market in 2025, while Asia-Pacific is projected to post the fastest growth.

Why it matters: - Arenavirus diagnostics help detect viral hemorrhagic fevers early. - Faster diagnosis can support timely treatment and outbreak control. - The market is expanding as infectious disease testing gets more investment and more use in clinical settings.

What happened: - The Business Research Company projected the arenavirus diagnostics market will grow from $1.31 billion in 2025 to $1.41 billion in 2026. - The firm expects the market to reach $1.91 billion by 2030. - The forecast implies a 7.9% compound annual growth rate from 2026 to 2030. - The release was issued May 13, 2026, from London.

The details: - Arenavirus diagnostics include PCR, serological assays and viral culture techniques used to detect arenavirus infections. - The market’s historical growth was tied to rising arenavirus infections, broader use of molecular diagnostics, growth in hospital and clinical lab infrastructure, higher demand for serological testing and more research into hemorrhagic fevers. - Future growth is expected to be driven by automated PCR and ELISA systems, rapid point-of-care tests, research expansion, AI-powered diagnostic analytics and more infectious disease funding. - Emerging trends include wider use of PCR-based tests, rapid diagnostic devices, next-generation sequencing, expanded testing services and tighter laboratory validation and quality assurance. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The market study also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company offers a free sample report and the full market report.

Between the lines: - The biggest demand driver is the rise in viral hemorrhagic fevers, which can cause multi-organ failure and high mortality. - The World Health Organization reported 877 confirmed Lassa fever cases in Nigeria in May 2023, with 152 deaths. - That was a 20% increase from 733 cases in the same period in 2022. - The release also points to healthcare infrastructure spending as a growth catalyst. - The UK Department of Health and Social Care announced $27.02 billion in hospital infrastructure funding in May 2023 under a new hospital programme. - The market opportunity appears tied not just to disease burden, but to lab modernization and broader diagnostic capacity.

What’s next: - Demand should keep building as hospitals, labs and research institutions adopt faster testing tools. - More growth is likely if automated PCR, ELISA and AI-enabled analytics move deeper into routine use. - The company expects expanded funding for infectious disease diagnostics to support the market through 2030.

The bottom line: - Arenavirus diagnostics is a niche but growing market, with outbreak detection needs and lab investment pushing steady expansion through the end of the decade.